Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Financing Cash Flow

-$2.20B

TTM · Period ending: Jun 30, 2026 · USD

VRTX Financing Cash Flow

Latest reported-$2.20Bperiod endingJun 30, 2026

Latest reported-$2.20Bperiod endingJun 30, 2026

VRTX TTM Cash from Financing (-$1.20M → -$2.20B)

TTM financing cash flow

High-resolution chart · PNG

VRTX financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period ending	Financing Cash Flow (USD)
Jun 30, 2001	366,359,000
Mar 31, 2001	373,563,000
Dec 31, 2000	544,031,000
Sep 30, 2000	534,333,000
Jun 30, 2000	189,743,000
Mar 31, 2000	180,259,000
Dec 31, 1999	2,800,000
Sep 30, 1999	2,000,000
Jun 30, 1999	2,600,000
Mar 31, 1999	3,500,000
Dec 31, 1998	4,200,000
Sep 30, 1998	5,700,000
Jun 30, 1998	5,300,000
Mar 31, 1998	16,000,000
Dec 31, 1997	164,800,000
Sep 30, 1997	165,800,000
Jun 30, 1997	242,800,000
Mar 31, 1997	236,800,000
Dec 31, 1996	87,100,000
Sep 30, 1996	85,200,000
Jun 30, 1996	7,200,000
Mar 31, 1996	1,800,000
Dec 31, 1995	1,800,000
Sep 30, 1995	16,000,000
Jun 30, 1995	15,600,000
Mar 31, 1995	14,800,000
Dec 31, 1994	71,900,000
Sep 30, 1994	56,600,000
Jun 30, 1994	56,400,000
Mar 31, 1994	59,500,000
Dec 31, 1993	1,600,000
Sep 30, 1993	1,700,000
Jun 30, 1993	1,900,000
Mar 31, 1993	-1,300,000
Dec 31, 1992	-1,200,000
Sep 30, 1992	24,400,000
Jun 30, 1992	50,700,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.